跳至主要内容
临床试验/NCT01587157
NCT01587157已完成3 期

Capnography During Percutaneous Transhepatic Cholangiodrainage (PTCD) (HepaBreath)

Technical University of Munich2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年8月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20
试验地点
2
主要终点
mean cumulative duration of detected apnea episodes per patient (capnographic vs. clinical surveillance)

研究概览

简要总结

Capnography provides noninvasive monitoring of ventilation and can allow early recognition of altered respiration patterns and apnea. The aim of this prospective study was to compare the detection of apnea and the prediction of oxygen desaturation and hypoxemia by capnography versus clinical surveillance during procedural sedation for percutaneous transhepatic cholangiodrainage (PTCD).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled for PTCD with midazolam and propofol sedation

排除标准

  • age less than 18 years
  • ASA class V
  • allergy to narcotic drugs
  • pregnancy
  • pre-existing hypotension, bradycardia or hypoxemia

结局指标

主要结局

mean cumulative duration of detected apnea episodes per patient (capnographic vs. clinical surveillance)

次要结局

  • overall number of detected episodes of apnea
  • the occurrences of oxygen desaturation and hypoxemia

研究者

发起方
Technical University of Munich
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验